| Apollo Commercial Real Estate Finance, Inc. Declares Initial Cash Liquidating Distribution |
Globe Newswire |
10/09 |
08:30 |
| Kaplan Fox Deadline Alert: UWM Holdings Corporation (NYSE: UWMC) Investors Have Until October 13, 2026 to Seek a Lead Plaintiff Role |
Globe Newswire |
10/09 |
08:15 |
| GF unveils roadmap to deliver the world’s most advanced FD-SOI platform for Physical AI |
Globe Newswire |
10/09 |
08:00 |
| New Crypto: Pepeto Announces Its Presale Passing $11 Million, With the BNB Price Prediction Now at $2,775 |
Globe Newswire |
10/09 |
08:00 |
| Fiverr to Release Third Quarter 2026 Results on October 29, 2026 |
Globe Newswire |
10/09 |
08:00 |
| AssetBuilt Announces Major U.S. Industrial Asset Sales Featuring Cutrale Florida, Aspen Aerogels Georgia, Jindal Films Oklahoma, Mil-Spec Los Angeles, R3 Lithium and Fortune 500 EV Manufacturing Assets in California |
Globe Newswire |
10/09 |
08:00 |
| VCI Global Clarifies Structure of US$125 Million Standby Equity Purchase Facility, Emphasizes Flexible Capital Strategy |
Globe Newswire |
10/09 |
08:00 |
| Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences |
Globe Newswire |
10/09 |
08:00 |
| OFA Group Completes Acquisition and Title Registration of Tokawa Coastal Property in Choshi, Japan |
Globe Newswire |
10/09 |
08:00 |
| Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial |
Globe Newswire |
10/09 |
08:00 |
| Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical |
Globe Newswire |
10/09 |
08:00 |
| Frontline Education and AI for Education Win Two Tech & Learning Best for Back to School Awards |
Globe Newswire |
10/09 |
08:00 |
| Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease |
Globe Newswire |
10/09 |
08:00 |
| Stride to Appoint Steven Guttentag and Dylan Haggart to Board of Directors and Form Capital Allocation Committee |
Globe Newswire |
10/09 |
08:00 |
| XMax to Acquire Hexa Creation, Developer of 1200V Vertical GaN Power Semiconductor Technology |
Globe Newswire |
10/09 |
08:00 |
| Black Rock Coffee Bar Continues Austin-Area Growth with New Killeen Location |
Globe Newswire |
10/09 |
08:00 |
| Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care |
Globe Newswire |
10/09 |
07:45 |
| Aura Announces Preliminary Record High Production in Q3 2026 and 9M 2026 Production Results |
Globe Newswire |
10/09 |
07:30 |
| Ethiopian police ask residents in Tigray regional capital to help restore order after rebel pullout |
AP Online |
10/09 |
07:21 |
| Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference |
Globe Newswire |
10/09 |
07:00 |
| Manhattan Bridge Capital, Inc. Announces Increase and Extension of its Existing Buy-Back of up to 250,000 of its Common Shares |
Globe Newswire |
10/09 |
07:00 |
| Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026 |
Globe Newswire |
10/09 |
07:00 |
| Wrap Appoints Veteran Law Enforcement Leader John “Chappy” Chapman as Vice President of Training and Missions |
Globe Newswire |
10/09 |
07:00 |
| Robbins Geller Rudman & Dowd LLP, Girard Sharp LLP, and The Hall Firm, Ltd. Attorneys File Securities Class Action Against Compass, Inc. (NYSE: COMP) |
Globe Newswire |
10/09 |
07:00 |
| Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia |
Globe Newswire |
10/09 |
07:00 |
